Arca Biopharma reported $0 in Debt for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Amgen AMGN:US $ 36854M 3545M
Arca Biopharma ABIO:US $ 0M 0M
Biogen BIIB:US $ 7275.2M 2.1M
Brainstorm Cell Therapeutics BCLI:US $ 0M 0M
Bristol Myers Squibb BMY:US $ 44972M 419M
Capricor Therapeutics CAPR:US $ 3.38M 0M
Cytokinetics CYTK:US $ 197.98M 55.14M
Cytrx CYTR:US 0 0
Daiichi Sankyo 4568:JP Y 163461M 93M
Gilead Sciences GILD:US $ 26208M 487M
GlaxoSmithKline GSK:LN 33328M 9155M
Laboratory Of America LH:US $ 5478.5M 34.6M
Myriad Genetics MYGN:US $ 0M 0M
Otsuka Holdings 4578:JP Y 211873M 580M
Pfizer PFE:US $ 36301M 2135M
United Therapeutics UTHR:US $ 800M 0M